Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DOCS
DOCS logo

DOCS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Doximity Inc (DOCS) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast DOCS stock price to rise
18 Analyst Rating
Wall Street analysts forecast DOCS stock price to rise
14 Buy
4 Hold
0 Sell
Strong Buy
Current: 26.030
sliders
Low
25
Averages
42.75
High
63
Current: 26.030
sliders
Low
25
Averages
42.75
High
63
Wells Fargo
Overweight
to
NULL
downgrade
$45 -> $32
AI Analysis
2026-05-11
New
Reason
Wells Fargo
Price Target
$45 -> $32
AI Analysis
2026-05-11
New
downgrade
Overweight
to
NULL
Reason
Wells Fargo lowered the firm's price target on Doximity to $32 from $45 and keeps an Overweight rating on the shares. Negative sentiment appears to reflect risks to market growth and pressure on wallet share, the firm says, adding that both appear priced in. With that said, Wells' recent key opinion leader call points to share stability alongside improving market ad growth.
Truist
Buy
to
Hold
downgrade
$37 -> $29
2026-04-20
Reason
Truist
Price Target
$37 -> $29
2026-04-20
downgrade
Buy
to
Hold
Reason
Truist downgraded Doximity to Hold from Buy with a price target of $29, down from $37. The firm has a taken a more cautious outlook on Doximity, saying its revenue growth visibility has softened and structural risks are mounting. There is limited clarity on pharma digital marketing budgets, the analyst tells investors in a research note. Truist believes Doximity's fiscal 2027 growth profile will likely be below consensus while it faces emerging competitive pressure from AI-native platforms such as OpenEvidence.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DOCS
Unlock Now

People Also Watch